423 related articles for article (PubMed ID: 15172624)
1. Biological qualification of blood units: considerations about the effects of sample's handling and storage on stability of nucleic acids.
Gessoni G; Barin P; Valverde S; Giacomini A; Di Natale C; Orlandini E; Arreghini N; De Fusco G; Frigato A; Fezzi M; Antico F; Marchiori G
Transfus Apher Sci; 2004 Jun; 30(3):197-203. PubMed ID: 15172624
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
Koppelman MH; Sjerps MC; Reesink HW; Cuypers HT
Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751
[TBL] [Abstract][Full Text] [Related]
3. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
Nübling CM; Unkelbach U; Chudy M; Seitz R
Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
[TBL] [Abstract][Full Text] [Related]
4. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
5. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
Japanese Red Cross NAT Screening Research Group
Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
[TBL] [Abstract][Full Text] [Related]
6. Stability of hepatitis C virus, HIV, and hepatitis B virus nucleic acids in plasma samples after long-term storage at -20°C and -70°C.
Baleriola C; Johal H; Jacka B; Chaverot S; Bowden S; Lacey S; Rawlinson W
J Clin Microbiol; 2011 Sep; 49(9):3163-7. PubMed ID: 21752974
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System.
Xiao X; Zhai J; Zeng J; Tian C; Wu H; Yu Y
J Virol Methods; 2013 Feb; 187(2):357-61. PubMed ID: 23142222
[TBL] [Abstract][Full Text] [Related]
8. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
[TBL] [Abstract][Full Text] [Related]
9. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
[TBL] [Abstract][Full Text] [Related]
12. Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.
Yang Z; Xu L; Liu L; Feng Q; Zhang L; Ma W; Saldanha J; Wang M; Zhao L
Transfusion; 2013 Oct; 53(10 Pt 2):2538-44. PubMed ID: 23480568
[TBL] [Abstract][Full Text] [Related]
13. Stability of HCV, HIV-1 and HBV nucleic acids in plasma samples under long-term storage.
José M; Gajardo R; Jorquera JI
Biologicals; 2005 Mar; 33(1):9-16. PubMed ID: 15713552
[TBL] [Abstract][Full Text] [Related]
14. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
Shang G; Yan Y; Yang B; Shao C; Wang F; Li Q; Seed CR
Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161
[TBL] [Abstract][Full Text] [Related]
15. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
16. Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors.
Dettori S; Candido A; Kondili LA; Chionne P; Taffon S; Genovese D; Iudicone P; Miceli M; Rapicetta M
J Infect; 2009 Aug; 59(2):128-33. PubMed ID: 19586663
[TBL] [Abstract][Full Text] [Related]
17. Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system.
Ohhashi Y; Pai A; Halait H; Ziermann R
J Virol Methods; 2010 May; 165(2):246-53. PubMed ID: 20152864
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.
Margaritis AR; Brown SM; Seed CR; Kiely P; D'Agostino B; Keller AJ
Transfusion; 2007 Oct; 47(10):1783-93. PubMed ID: 17880602
[TBL] [Abstract][Full Text] [Related]
19. HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors.
Wiedmann M; Kluwick S; Walter M; Fauchald G; Howe J; Bronold M; Zauke M
J Clin Virol; 2007 Aug; 39(4):282-7. PubMed ID: 17611148
[TBL] [Abstract][Full Text] [Related]
20. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
